Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kolb

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Elife|December 1, 2021
Disentangling bias between G<sub>q</sub>, GRK2, and arrestin3 recruitment to the M<sub>3</sub> muscarinic acetylcholine receptorAnja Flöser, Katharina Becker, Evi Kostenis, et al.
Brain Research|March 2, 2010
Differences in unconditioned and conditioned responses of the human withdrawal reflex during stance: muscle responses and biomechanical dataThomas Kaulich, Wolfram Föhre, Dieter Friedhelm Kutz, et al.
Inorganic Chemistry|February 14, 1996
Tetrachloro- and Tetrabromostibonium(V) Cations: Raman and (19)F, (121)Sb, and (123)Sb NMR Spectroscopic Characterization and X-ray Crystal Structures of SbCl(4)(+)Sb(OTeF(5))(6)(-) and SbBr(4)(+)Sb(OTeF(5))(6)(-)William J. Casteel, Peter Kolb, Nicolas LeBlond, et al.
Molecules (Basel, Switzerland)|February 25, 2023
NMR-Based Metabolite Profiling and the Application of STOCSY toward the Quality and Authentication Assessment of European EVOOsStavros Beteinakis, Anastasia Papachristodoulou, Peter Kolb, et al.
Molecular Pharmacology|November 9, 2022
The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human <i>β</i>1-AdrenoceptorVictor Jun Yu Lim, Richard G W Proudman, Stefania Monteleone, et al.
Plos One|November 28, 2012
Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonistsPeter Kolb, Khai Phan, Zhan-Guo Gao, et al.
Chemmedchem|March 19, 2016
Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential AntipsychoticsAgnieszka A Kaczor, Andrea G Silva, María I Loza, et al.
European Journal of Medicinal Chemistry|June 4, 2025
Docking for Smoothened antagonist chemotypes not susceptible to a vismodegib-resistance mutationWillem H C Titulaer, Sebastian Klindert, Corey Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2019
Interrogating dense ligand chemical space with a forward-synthetic libraryFlorent Chevillard, Silvia Stotani, Anna Karawajczyk, et al.
Journal of Medicinal Chemistry|August 5, 2005
Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculationsDanzhi Huang, Urs Lüthi, Peter Kolb, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Elife|December 1, 2021
Disentangling bias between G<sub>q</sub>, GRK2, and arrestin3 recruitment to the M<sub>3</sub> muscarinic acetylcholine receptorAnja Flöser, Katharina Becker, Evi Kostenis, et al.
Brain Research|March 2, 2010
Differences in unconditioned and conditioned responses of the human withdrawal reflex during stance: muscle responses and biomechanical dataThomas Kaulich, Wolfram Föhre, Dieter Friedhelm Kutz, et al.
Inorganic Chemistry|February 14, 1996
Tetrachloro- and Tetrabromostibonium(V) Cations: Raman and (19)F, (121)Sb, and (123)Sb NMR Spectroscopic Characterization and X-ray Crystal Structures of SbCl(4)(+)Sb(OTeF(5))(6)(-) and SbBr(4)(+)Sb(OTeF(5))(6)(-)William J. Casteel, Peter Kolb, Nicolas LeBlond, et al.
Molecules (Basel, Switzerland)|February 25, 2023
NMR-Based Metabolite Profiling and the Application of STOCSY toward the Quality and Authentication Assessment of European EVOOsStavros Beteinakis, Anastasia Papachristodoulou, Peter Kolb, et al.
Molecular Pharmacology|November 9, 2022
The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human <i>β</i>1-AdrenoceptorVictor Jun Yu Lim, Richard G W Proudman, Stefania Monteleone, et al.
Plos One|November 28, 2012
Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonistsPeter Kolb, Khai Phan, Zhan-Guo Gao, et al.
Chemmedchem|March 19, 2016
Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential AntipsychoticsAgnieszka A Kaczor, Andrea G Silva, María I Loza, et al.
European Journal of Medicinal Chemistry|June 4, 2025
Docking for Smoothened antagonist chemotypes not susceptible to a vismodegib-resistance mutationWillem H C Titulaer, Sebastian Klindert, Corey Taylor, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2019
Interrogating dense ligand chemical space with a forward-synthetic libraryFlorent Chevillard, Silvia Stotani, Anna Karawajczyk, et al.
Journal of Medicinal Chemistry|August 5, 2005
Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculationsDanzhi Huang, Urs Lüthi, Peter Kolb, et al.
Pageof 10